Actively Recruiting

All Genders
ID06991517

A Prospective Cohort Study of Bicuspid Case Selection and Valve Sizing Using the ABC Bicuspid Sizing Algorithm for Sapien 3 Balloon Expandable Valve

Led by World Health Research Inc. · Updated on 2025-11-28

290

Participants Needed

21

Research Sites

52 weeks

Total Duration

On this page

Sponsors

W

World Health Research Inc.

Lead Sponsor

E

Edwards Lifesciences

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating the effects of the ABC Bicuspid Sizing Algorithm on patients with bicuspid aortic stenosis who undergo transcatheter aortic valve replacement (TAVR) using the Sapien 3 valve. This international, prospective cohort study aims to determine if the algorithm improves technical success immediately after the procedure and device success 30 days post-procedure. The study includes about 290 patients being considered for TAVR or surgical aortic valve replacement (SAVR). The ABC Bicuspid Sizing Algorithm helps physicians decide between TAVR and SAVR and guides valve sizing and deployment for TAVR patients. It incorporates diagnostic CT scans and may include gated computed tomography or artificial intelligence-based simulations in some cases to assess borderline feasibility. Approximately 230 patients will undergo TAVR based on the algorithm's recommendations, while others will have SAVR. Treatment decisions are made using the algorithm alongside clinical judgment. Participants will have data collected at several points: baseline, during the procedure, at hospital discharge, and at 30 days and one year after the procedure if treated with TAVR. SAVR patients will have data collected at baseline and during the procedure only. Outcomes measured include technical and device success, conduction disturbances, vascular complications, stroke, valve function, and survival. The study lasts through the one-year follow-up after the procedure, involving multiple clinical assessments and imaging reviews.

CONDITIONS

Brief Title

A Study of Transcatheter Aortic Valve Replacement Case Selection and Valve Sizing Using the ABC Bicuspid Sizing Algorithm

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Have bicuspid aortic valve disease
  • Have severe aortic stenosis or mixed aortic stenosis and regurgitation requiring treatment
  • Have no other condition requiring surgical intervention
  • Have had a TAVR CT scan of diagnostic quality including multiphase reconstructions of the aortic root
  • Would be treated with a Sapien 3 valve if anatomically suitable for TAVR
  • Have a suitable access route for TAVR with a Sapien 3 valve
Not Eligible

You will not qualify if you...

  • Treated with TAVR using a device other than a Sapien 3 valve
  • Unable to be treated with TAVR due to intercurrent illness, clinical instability, or death on waitlist after acceptance for TAVR

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Baseline period

Participants undergo evaluation using the ABC Bicuspid Sizing Algorithm, including CT scans and possibly gated CT evaluation or AI-based simulation models to help guide treatment decisions between TAVR and surgical aortic valve replacement.

1 visit (in-person)

Treatment

Duration - Procedure day

Participants receive treatment with either transcatheter aortic valve replacement (TAVR) using a Sapien 3 valve or surgical aortic valve replacement (SAVR) as determined by the treating physicians based on the algorithm and clinical factors.

1 visit (procedure day)

Hospital Discharge Monitoring

Duration - Until hospital discharge

Participants treated with TAVR are monitored during their hospital stay after the procedure.

Approximately 1 to 2 visits during hospital stay

Post-treatment Follow-up

Duration - 1 year

Participants treated with TAVR have follow-up visits for safety and outcome assessments at 30 days and 1 year after the procedure.

2 visits (at 30 days and 1 year post-procedure)

Trial Site Locations

Total: 21 locations

1

John Hunter Hospital

New Lambton Heights, New South Wales, Australia, 2305

Not Yet Recruiting

2

North Shore Private Hospital

St Leonards, New South Wales, Australia, 2065

Not Yet Recruiting

3

Royal North Shore Hospital

St Leonards, New South Wales, Australia, 2065

Actively Recruiting

4

The Prince Charles Hospital

Chermside, Queensland, Australia, 4032

Not Yet Recruiting

5

St Andrew's War Memorial Hospital

Spring Hill, Queensland, Australia, 4000

Not Yet Recruiting

6

The Alfred

Melbourne, Victoria, Australia, 3004

Actively Recruiting

7

Fiona Stanley Hospital

Murdoch, Western Australia, Australia, 6150

Not Yet Recruiting

8

Foothills Medical Centre

Calgary, Alberta, Canada, T2N 2T9

Not Yet Recruiting

9

NovaScotia Health Authority- Halifax Infimary

Halifax, NovaScotia, Canada, B3H 3A7

Not Yet Recruiting

10

Hamilton General Hospital

Hamilton, Ontario, Canada, L8L 2X2

Actively Recruiting

11

Southlake Regional Health Centre

Newmarket, Ontario, Canada, L3Y 2P9

Not Yet Recruiting

12

University of Ottawa Heart Institute

Ottawa, Ontario, Canada, K1Y 4W7

Actively Recruiting

13

St. Michael's Hospital

Toronto, Ontario, Canada, M5B 1W8

Actively Recruiting

14

Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval

Québec, Quebec, Canada, G1V 4G5

Actively Recruiting

15

Fundación Cardioinfantil - LaCardio

Bogotá, Colombia, 111011

Not Yet Recruiting

16

Hospital San Juan de Dios

San José, Provincia de San José, Costa Rica, 10104

Not Yet Recruiting

17

Centro Médico Nacional Siglo XXI

Mexico City, Mexico, 06720

Not Yet Recruiting

18

Instituto Nacional de Cardiología - Ignacio Chávez

Mexico City, Mexico, 14080

Not Yet Recruiting

19

Wellington Regional Hospital

Newtown, Wellington Region, New Zealand, 6021

Not Yet Recruiting

20

National Heart Centre Singapore

Singapore, Singapore, 169609

Actively Recruiting

21

Ramathibodi Hospital

Bangkok, Thailand, 10400

Not Yet Recruiting

Loading map...

Research Team

S

Sarah Tawadros, MD

F

Frank Naus

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

A Randomized Double-blind, Placebo-controlled, Multicenter T...

Aortic Stenosis

Actively Recruiting

139 locations

Artificial Intelligence-Based Assessment of Low-Gradient Aor...

Low-gradient Aortic Stenosis

Actively Recruiting

1 location

Clinical Utility of AI-Enabled Electrocardiograms to Diagnos...

Aortic Stenosis

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here